Efficacy and Safety of Semaglutide for the Management of Obese Patients With Type 2 Diabetes and Chronic Heart Failure in Real-World Clinical Practice

Overview of attention for article published in Frontiers in endocrinology, June 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 62 Mendeley

So far, Altmetric has seen 1 X post from an account with 4,897 followers.

New Research: Efficacy and Safety of Semaglutide for the Management of Obese Patients With Type 2 Diabetes and Chronic Heart Failure in Real-World Clinical Practice: Background The impact of glucagon-like peptide-1 receptor agonists… https://t.co/w7OpHl9X

24 Jun 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.